Page last updated: 2024-09-05

dabigatran and Brain Hemorrhage

dabigatran has been researched along with Brain Hemorrhage in 128 studies

Research

Studies (128)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	103 (80.47)	24.3611
2020's	25 (19.53)	2.80

Authors

Authors	Studies
Horwitz, H; Jimenez-Solem, E; Nyeland, ME; Schelde, AB; von Osmanski, BI	1
Atzema, CL; Austin, PC; Borgundvaag, B; de Wit, K; Grewal, K; McLeod, SL; Mittmann, N; Sharma, S	1
Archontakis-Barakakis, P; Batsidis, A; Giamouzis, G; Giannakoulas, G; Giannopoulos, S; Kalaitzoglou, D; Kokkinidis, DG; Li, W; Lip, GYH; Manolopoulos, A; Ntaios, G; Palaiodimos, L; Tzelves, L	1
Chiba, T; Egashira, S; Ihara, M; Inoue, M; Kimura, S; Koga, M; Okada, T; Shiozawa, M; Takashima, H; Toyoda, K; Wada, S; Yoshimoto, T; Yoshimura, S	1
Frol, S; Kermer, P; Oblak, JP; Šabovič, M	1
Andreone, V; Anticoli, S; Barbarini, L; Biguzzi, S; Caggiula, M; Candelaresi, P; Caso, V; Cenciarelli, S; Colangeli, E; Concari, L; Cordici, F; De Angelis, MV; Dell'Aera, C; Diana, F; Digiovanni, A; Eusebi, P; Fortunata Musolino, R; Gentile, M; Giammello, F; Giannandrea, D; Giorli, E; La Gioia, S; Longoni, M; Mangiardi, M; Matteo, E; Migliaccio, L; Mosconi, MG; Muto, M; Naccarato, M; Paciaroni, M; Petruzzellis, M; Pronello, E; Ricci, S; Rizzo, F; Romoli, M; Ruggiero, M; Sacco, S; Scura, GM; Sepe, FN; Sessa, M; Toni, D; Zedde, ML; Zini, A	1
Alves da Silva, P; Caldeira, D; Pinto, FJ	1
Brinkmann, M; Diener, HC; Eschenfelder, CC; Gröschel, K; Grosse, GM; Hüsing, A; Kuklik, N; Michalski, D; Nabavi, D; Poli, S; Royl, G; Sparenberg, P; Stang, A; Weimar, C; Weissenborn, K	1
Chan, YH; Fong, KY; Lip, GYH; Tan, VH; Yeo, C	1
Huang, KC; Lee, JK; Lin, DS; Lin, TT; Lo, HY	1
Abdalla, Y; Abraham, A; Althaus, K; Becks, G; Berrouschot, J; Berthel, J; Bode, FJ; Burghaus, L; Cangür, H; Daffertshofer, M; Diener, HC; Edelbusch, S; Eggers, J; El-Sabassy, H; Eschenfelder, CC; Gerlach, R; Grond, M; Gröschel, K; Große-Dresselhaus, F; Günther, A; Haase, CG; Haensch, CA; Harloff, A; Heckmann, JG; Held, V; Hieber, M; Kauert, A; Kermer, P; Kern, R; Kerz, T; Köhrmann, M; Kraft, P; Kühnlein, P; Latta, J; Leinisch, E; Leithner, C; Lenz, A; Mäurer, M; Müllges, W; Neumann-Haefelin, T; Nolte, CH; Obermann, M; Partowi, S; Patzschke, P; Poli, S; Pulkowski, U; Purrucker, J; Rehfeldt, T; Ringleb, PA; Rossi, R; Röther, J; Sarnowksi, BV; Sauer, O; Schackert, G; Schäfer, N; Schellinger, PD; Schneider, A; Schuppner, R; Schwab, S; Schwarte, O; Seitz, RJ; Senger, S; Shah, YP; Sindern, E; Sparenberg, P; Steiner, T; Szabo, K; Urbanek, C; Weissenborn, K; Wienecke, P; Witt, K; Wruck, R; Wunderlich, S	1
Bernstein, RA; Clark, CL; Douketis, J; Fanikos, J; Fermann, GJ; Fiore, GJ; Frost, A; Jahromi, B; Johnson, C; Merli, G; Peacock, WF; Pollack, CV; Silber, S; Villines, TC	1
Beharry, J; Campbell, BCV; Drew, R; Fink, JN; Kleinig, TJ; Parsons, MW; Waters, MJ; Wilson, D; Wu, TY	1
Liu, X; Xu, ZX; Yu, P; Yuan, P; Zhu, WG	1
Bauersachs, J; Berliner, D; Flierl, U; Schäfer, A	1
Chao, TF; Chen, SJ; Chen, TJ; Jiang, YR; Liao, JN; Tsai, CT	1
Frol, S; Hudnik, LK; Oblak, JP; Šabovič, M; Sernec, LP	1
Beharry, JM; Hanger, HC; Mee, HJ; Wilkinson, TJ; Wu, TY	1
Chen, W; Jiang, S; Lv, C; Lv, M; Wu, L; Wu, T; Zhang, J	1
Côté, R; Dorais, M; Martel, MJ; Perreault, S; Qazi, JZ; Schnitzer, ME	1
Chaudhry, UA; Ezekowitz, MD; George, WT; Gracely, EJ; Harper, G; Harper, GR; Wolfe, CM	1
Abenhaim, L; Benichou, J; Davy, JM; Dialla, O; Ferrières, J; Grimaldi-Bensouda, L; Le Heuzey, JY; Leys, D; Martinez, M; Nighoghossian, N; Nordon, C; Smadja, D; Touzé, E	1
Jiang, H; Jiang, Y; Lv, J; Ma, H; Zeng, H	1
Chen, J; Chen, M; Fang, Z; Jiang, S; Lv, M; Qian, J; Wu, S; Xu, W; Zeng, Z; Zhang, J	1
Connolly, SJ; Eikelboom, JW; Hirsh, J; Quinlan, DJ; Weitz, JI	1
Bissig, D; Manjunath, R; Ng, KL; Richman, DP; Traylor, BR	1
Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M	1
Chan, KA; Chen, HM; Lai, CL; Liao, MT; Lin, TT	1
Abdalla, Y; Althaus, K; Berrouschot, J; Cangür, H; Daffertshofer, M; Diener, HC; Edelbusch, S; Eschenfelder, CC; Grond, M; Gröschel, K; Haase, CG; Harloff, A; Held, V; Kauert, A; Kermer, P; Kraft, P; Lenz, A; Müllges, W; Obermann, M; Partowi, S; Purrucker, J; Ringleb, PA; Rossi, R; Röther, J; Schäfer, N; Schneider, A; Schuppner, R; Seitz, RJ; Szabo, K; Wruck, R	1
Frossard, M; Koch, S; Pausch, A; Wiegele, M	1
Hu, SJ; Wu, T; Xu, WW	1
Jolobe, OM	1
Jolobe, OMP	1
Fang, CW; Hsiao, YJ; Lin, FY; Lu, CH; Tsai, LK; Tsai, YT; Yen, PS	1
Khan, SU; Lash, B; Nasir, F; Raghu Subramanian, C; Wolfe, Z	1
Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T	1
Bai, Y; Carmo, J; Esteve-Pastor, MA; Lip, GYH; Marín, F; Orenes-Piñero, E; Proietti, M; Rivera-Caravaca, JM; Roldán, V; Romanazzi, I; Romiti, GF	1
Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR	1
Sheikh-Taha, M	1
Barmparas, G; Coimbra, R; Dhillon, NK; Kobayashi, L; Ley, EJ; Margulies, DR; Patel, KA	1
Bhatt, DL; Federspiel, JJ; Fonarow, GC; Hernandez, AF; Huang, RJ; Jin, C; Laskowitz, DT; Peterson, ED; Schwamm, LH; Smith, EE; Xian, Y	1
Alcusky, M; Fisher, M; Goldberg, RJ; Hume, AL; Lapane, KL; McManus, DD; Tjia, J	1
Hirakawa, T; Ishida, K; Koretsune, Y; Kuroki, D; Ono, Y; Sumida, T; Urushihara, H; Yamashita, T; Yasaka, M	1
Baser, O; Deitelzweig, S; Friend, K; Gupta, K; Hamilton, M; Keshishian, A; Li, X; Lip, GYH; Luo, X; Mardekian, J; Masseria, C; Nadkarni, A; Pan, X	1
Cowperthwaite, M; Fanale, C; Nadasdy, Z; Ramakrishnan, A; Shpak, M	1
Akamatsu, Y; Hayashi, T; Kameyama, M; Karibe, H; Narisawa, A	1
Campodonico, P; Guiddo, G; Lerza, R; Malerba, M; Minuto, P; Motta, G; Riccardi, A; Spinola, MB	1
Kasper, EM; Lu, VM; Phan, K; Rao, PJ; Sharma, SV	1
Benarousse, G; Crisan, O; Elalamy, I; Gruenenfelder, F; Tazarourte, K	1
Boling, B; Nestor, MA	1
Chen, H; Deng, Y; Li, S; Tong, Y; Zou, L	1
Belk, KW; Nautiyal, A; Singh, S	1
Clark, WM; Horowitz, BZ; Javedani, PP; Lutsep, HL	1
Reichman, ME; Southworth, MR; Unger, EF	1
Arkin, CF; Aron, JL; Gosselin, R; Mantha, S; Moll, S	1
Callréus, T; Due, KM; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F	1
Awad, AJ; Coumans, JV; Nahed, BV; Stapleton, CJ; Walcott, BP; Yanamadala, V	1
Abel, TJ; Greenlee, JD; Grossbach, A; Howard, MA; Jackson, AW; Viljoen, SV; Wassef, SN	1
Chen, JH; Connolly, SJ; Dans, AL; Ezekowitz, MD; Hori, M; Kim, SS; Koyanagi, M; Lau, CP; Liu, LS; Omar, R; Pais, P; Reilly, PA; Tan, RS; Tanomsup, S; Wallentin, L; Watanabe, M; Xavier, D; Yusuf, S; Zhu, J	1
Bosnyák, E; Csécsei, P; Deli, G; Fehér, G; Szapary, L	1
Lip, GY; Potpara, TS	1
Bennaghmouch, N; Ten Berg, JM	1
Diener, HC; Easton, JD; Hankey, GJ; Hart, RG	1
Barco, S; Cheung, YW; Coppens, M; Eikelboom, JW	1
Kansal, AR; Pokora, T; Sorensen, SV; Zheng, Y	1
Schulman, S	1
Abe, K; Deguchi, K; Ikeda, Y; Kono, S; Kurata, T; Omote, Y; Yamashita, T; Yunoki, T	1
Ditch, K; Miller, MA; Ross, B; Tran, M	1
Berrut, G; Chevalet, P; De Decker, L; Gegu, M; Piloquet, FX	1
Ago, T; Fujimoto, S; Kameda, K; Kitazono, T; Kokuba, K; Komori, M; Matsuoka, H; Nagata, S; Okada, Y; Shono, T; Yasaka, M; Yoshida, M	1
Henry, BL; Kumar, R; Smith, RE	1
Hirano, T	1
Alonso, A; Bengtson, LG; Chen, LY; Lakshminarayan, K; Lutsey, PL; MacLehose, RF	1
Byrne, RW; Kasliwal, MK; Lopes, DK; Moftakhar, R; Munoz, LF; Panos, NG	1
Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS	1
Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R	1
Eikelboom, JW; Hart, RG	1
Chan, KH; Chan, PH; Cheung, E; Hai, JJ; Ho, CW; Ho, MH; Lau, CP; Lau, KK; Leung, GK; Lip, GY; Siu, CW; Tse, HF; Yeung, CY	1
Greinacher, A; Selleng, K; Thiele, T	1
Abdollah, H; Baranchuk, A; Enriquez, A; Michael, K; Redfearn, D; Simpson, C	1
Bnouhanna, W; Cho, TH; Davenas, C; Derex, L; Farghali, A; Mechtouff, L; Nighoghossian, N; Ritzenthaler, T	1
Abe, J; Kato, Y; Kinosada, Y; Nagasawa, H; Nakamura, M; Nakayama, Y; Suzuki, T; Suzuki, Y; Ueda, N; Umetsu, R	1
Hsieh, CY; Hsu, JC; Lu, CY; Yang, YH	1
Hendrickson, JE; Rinder, HM; Siddon, AJ; Tormey, CA	1
Caldeira, D; Costa, J; Ferreira, JJ; Gonçalves, N; Pinto, FJ	1
Beavers, C; Pahs, L; Schuler, P	1
Ganetsky, M	1
Avgil-Tsadok, M; Behlouli, H; Eisenberg, MJ; Essebag, V; Jackevicius, CA; Pilote, L; Rahme, E	1
Chan, EW; Chan, PH; Chiang, CE; Hai, JJ; Huang, D; Lau, CP; Li, WH; Siu, CW; Tse, HF; Wong, IC; Yin, LX; Zhu, J	1
Grotts, J; Kaminski, S; Pozzessere, A	1
Eikelboom, J; Weitz, JI	1
Bouget, J; Oger, E	1
Kanorsky, SG; Shevelev, VI	1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC	1
Hendrix, P; Keiner, D; Oertel, J; Senger, S	1
Breuer, L; Kallmünzer, B; Köhrmann, M; Kurka, N; Ringwald, J; Schwab, S; Volbers, B	1
Dolginsky, M; Kym, E; Nolting, L; Orrico, KB; Romanelli, RJ	1
Brueckmann, M; Clemens, A; Connolly, SJ; Diener, HC; Eikelboom, J; Ezekowitz, MD; Kent, AP; Noack, H; Oldgren, J; Pogue, J; Reilly, PA; Spahr, J; Wallentin, L; Yusuf, S	1
Gauthier-Lewis, ML; Riley, TR; Riley, TT; Sanchez, CK	1
Aita, A; Angeli, F; Bartolini, C; Reboldi, G; Verdecchia, P	1
Aksoy, H; Ata, N; Ayturk, M; Dal, K; Ozkan, S; Ozturk, M; Şabanoglu, C; Tanalp, AC; Topaloglu, C; Yavuz, B; Yavuz, BB	1
Cigarroa, J; Henrikson, CA; Steinberg, JS; Tereshchenko, LG	1
Battat, E; Bitterman, H; Dotan, SG; Eikelboom, JW; Ellis, MH; Ginsberg, JS; Hammerman, A; Hirsh, J; Neuman, T	1
Ageno, W; Eikelboom, J; Lip, GY	1
Berger, K; Lesch, CA; Sin, JH	1
Milling, TJ; Spyropoulos, AC	2
Dellegrottaglie, S; Filippatos, G; Giugliano, RP; Lund, LH; Magnani, G; McMurray, J; Perrone-Filardi, P; Rosano, GM; Savarese, G; Trimarco, B	1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH	1
Bonde, AN; Fosbøl, EL; Gerds, TA; Gislason, GH; Lamberts, M; Lip, GYH; Olesen, JB; Ozenne, B; Staerk, L; Torp-Pedersen, C	1
Flores, JJ; Klebe, D; Krafft, PR; Lekic, T; McBride, DW; Rolland, WB; Zhang, JH	1
Terayama, Y	1
Cong, J; Fromm, C; Ganetsky, M; Milling, TJ; Pallin, DJ; Singer, AJ	1
Bocksrucker, C; Drwiła, R; Dulíček, P; Hauer, T; Mutzenbach, J; Schlimp, CJ; Špinler, D; Vosko, MR; Wolf, T; Zugwitz, D	1
Desborough, MJ; Shapiro, S; Zhang, XY	1
Spinler, SA	1
Freeman, JV; Garber, AM; Go, AS; Hutton, DW; Owens, DK; Turakhia, MP; Wang, PJ; Zhu, RP	1
Aikens, TH; Chernick, MR; Connolly, SJ; Ezekowitz, MD; Lip, GY; Parekh, A; Pogue, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S	1
Bradley-Kennedy, C; Connolly, S; Kansal, AR; Linnehan, J; Peng, S; Plumb, JM; Sorensen, SV	1
del Zoppo, GJ; Eliasziw, M	1
Brueckmann, M; Clemens, A; Eikelboom, J; Healey, JS; Oldgren, J; Sinnaeve, PR	1
Banerjee, A; Lane, DA; Lip, GY; Torp-Pedersen, C	1
Engh, JA; Parry, PV	1
Connolly, SJ; Eikelboom, JW; Hart, RG; Quinlan, DJ; Yusuf, S	1
Connolly, SJ; Diener, HC; Ezekowitz, MD; Hart, RG; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S	1
Chang, DN; Chin, AI; Dager, WE	1
Connolly, SJ; Coppens, M; Dale, B; Eikelboom, JW; Ginsberg, JS; Hirsh, J; Paikin, JS; Weitz, JI; Whitlock, RP; Young, E	1
Cucchiara, B; Kasner, SE; Messe, S; Mullen, MT; Rybinnik, I	1

Reviews

41 review(s) available for dabigatran and Brain Hemorrhage

Article	Year
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies. British journal of clinical pharmacology, 2022, Volume: 88, Issue:11 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Humans; Intracranial Hemorrhages; Ischemic Stroke; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2022
Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke. Journal of thrombosis and thrombolysis, 2023, Volume: 55, Issue:3 Topics: Antithrombins; Dabigatran; Hemorrhagic Stroke; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke	2023
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis. European stroke journal, 2023, Volume: 8, Issue:1 Topics: Anticoagulants; Antithrombins; Brain Ischemia; Dabigatran; Humans; Intracranial Hemorrhages; Ischemic Stroke; Multicenter Studies as Topic; Observational Studies as Topic; Stroke; Thrombolytic Therapy	2023
Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk. The American journal of cardiology, 2023, 10-01, Volume: 204 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Intracranial Hemorrhages; Risk Factors; Stroke; Treatment Outcome; Warfarin	2023
Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 2023, Dec-05, Volume: 12, Issue:23 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke	2023
Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies. Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:4 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Observational Studies as Topic; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Secondary Prevention; Stroke; Thiazoles; Treatment Outcome; Vitamin K; Warfarin	2020
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients. Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:4 Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Vitamin K; Warfarin	2020
Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. Journal of neurology, 2022, Volume: 269, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Intracranial Hemorrhages; Randomized Controlled Trials as Topic; Stroke	2022
Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis. Clinical cardiology, 2021, Volume: 44, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Rivaroxaban; Stroke; Warfarin	2021
Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Rivaroxaban; Stroke; Vitamin K	2023
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review. JAMA cardiology, 2017, 05-01, Volume: 2, Issue:5 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Chromatography, High Pressure Liquid; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Intracranial Hemorrhages; Partial Thromboplastin Time; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Tandem Mass Spectrometry; Thiazoles; Thrombin Time; Warfarin	2017
Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis. Journal of Zhejiang University. Science. B, 2017, Volume: 18, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Clinical Trials as Topic; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Markov Chains; Middle Aged; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Pyridines; Randomized Controlled Trials as Topic; Risk; Thiazoles; Warfarin	2017
A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:7 Topics: Administration, Oral; Antithrombins; Bayes Theorem; Dabigatran; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Thiazoles; Treatment Outcome	2018
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke. Stroke, 2018, Volume: 49, Issue:9 Topics: Administration, Intravenous; Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Brain Ischemia; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Odds Ratio; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Tissue Plasminogen Activator	2018
Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature. Clinical neurology and neurosurgery, 2019, Volume: 181 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Dabigatran; Hemorrhage; Humans; Intracranial Hemorrhages	2019
Reversing Direct Oral Anticoagulants in Acute Intracranial Hemorrhage. Critical care nurse, 2019, Volume: 39, Issue:3 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzamides; Dabigatran; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thromboembolism; Treatment Outcome	2019
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 2019, 07-16, Volume: 8, Issue:14 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin	2019
Dabigatran, intracranial hemorrhage, and the neurosurgeon. Neurosurgical focus, 2013, Volume: 34, Issue:5 Topics: Aged, 80 and over; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Neurosurgery; Tomography, X-Ray Computed; Treatment Outcome	2013
Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature. Neurosurgery, 2013, Volume: 73, Issue:2 Topics: Accidental Falls; Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Craniocerebral Trauma; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male	2013
[Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran]. Ideggyogyaszati szemle, 2013, May-30, Volume: 66, Issue:5-6 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Intracranial Hemorrhages; Pyridines; Risk Assessment; Risk Factors; Stroke; Vitamin K	2013
Novel oral anticoagulants in non-valvular atrial fibrillation. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2013
New oral anticoagulants after acute coronary syndrome. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism	2013
Novel oral anticoagulants in secondary prevention of stroke. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Guidelines as Topic; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2013
New oral anticoagulants in elderly patients. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Vitamin K; Warfarin	2013
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin	2013
Advantages and limitations of the new anticoagulants. Journal of internal medicine, 2014, Volume: 275, Issue:1 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Disease Management; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2014
[General characteristics of the new oral anticoagulants]. Geriatrie et psychologie neuropsychiatrie du vieillissement, 2013, Volume: 11, Issue:1 Suppl Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Investigational; Humans; Iatrogenic Disease; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Vitamin K	2013
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience. Journal of intensive care medicine, 2015, Volume: 30, Issue:8 Topics: Anticoagulants; Antidotes; Antithrombins; Charcoal; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospitals, University; Humans; Intracranial Hemorrhages; Male; Multiple Organ Failure; Partial Thromboplastin Time; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome	2015
Reversal of anticoagulants: an overview of current developments. Thrombosis and haemostasis, 2015, Volume: 113, Issue:5 Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzamides; Clinical Trials as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Hemostatics; Heparin; Humans; Infusions, Parenteral; Intracranial Hemorrhages; Polysaccharides; Protamines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; Thrombosis; Vitamin K	2015
Dabigatran for the prevention and treatment of thromboembolic disorders. Expert review of cardiovascular therapy, 2015, Volume: 13, Issue:5 Topics: Animals; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Intracranial Hemorrhages; Stroke; Thromboembolism	2015
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015, Volume: 15, Issue:4 Topics: Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Humans; Intracranial Hemorrhages; Pharmacovigilance; Randomized Controlled Trials as Topic; Stroke	2015
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation. Thrombosis and haemostasis, 2016, Volume: 115, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Stroke; Thiazoles; Warfarin	2016
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis. Circulation. Cardiovascular quality and outcomes, 2016, Volume: 9, Issue:2 Topics: Age Factors; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Risk Factors; Stroke; Treatment Outcome; Warfarin	2016
Why switch from warfarin to NOACs? Internal and emergency medicine, 2016, Volume: 11, Issue:3 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Evidence-Based Medicine; Female; Humans; Intracranial Hemorrhages; Male; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Severity of Illness Index; Survival Rate; Treatment Outcome; Vitamin K; Warfarin	2016
Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis. Journal of the American Heart Association, 2016, 05-20, Volume: 5, Issue:5 Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin	2016
Dabigatran in clinical practice: Contemporary overview of the evidence. International journal of cardiology, 2016, Oct-01, Volume: 220 Topics: Antithrombins; Atrial Fibrillation; Clinical Trials as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Stroke; Venous Thromboembolism; Warfarin	2016
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed. The American journal of medicine, 2016, Volume: 129, Issue:11S Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism	2016
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis. JACC. Heart failure, 2016, Volume: 4, Issue:11 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Cause of Death; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Intracranial Hemorrhages; Mortality; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin	2016
Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed. The American journal of emergency medicine, 2016, Volume: 34, Issue:11S Topics: Antithrombins; Clinical Decision-Making; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Risk Assessment; Thromboembolism	2016
Reversal of direct oral anticoagulants. British journal of hospital medicine (London, England : 2005), 2017, Mar-02, Volume: 78, Issue:3 Topics: Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Arginine; Blood Coagulation Factors; Coagulants; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Partial Thromboplastin Time; Piperazines; Prothrombin Time; Recombinant Proteins; Thrombin Time	2017
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation. Journal of internal medicine, 2012, Volume: 271, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombin Proteins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Intracranial Hemorrhages; Pyridines; Risk Factors; Stroke	2012

Trials

8 trial(s) available for dabigatran and Brain Hemorrhage

Article	Year
Clinical Outcomes of Anticoagulated Patients With Atrial Fibrillation After Falls or Head Injury: Insights From RE-LY. Stroke, 2023, Volume: 54, Issue:6 Topics: Accidental Falls; Anticoagulants; Atrial Fibrillation; Craniocerebral Trauma; Dabigatran; Hemorrhage; Humans; Intracranial Hemorrhages; Retrospective Studies; Stroke; Warfarin	2023
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PloS one, 2018, Volume: 13, Issue:8 Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin	2018
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke, 2013, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asia; Asian People; Atrial Fibrillation; Benzimidazoles; Brain Ischemia; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyridines; Stroke; Warfarin	2013
[COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION]. Klinicheskaia meditsina, 2015, Volume: 93, Issue:7 Topics: Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Monitoring; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Treatment Outcome; Warfarin	2015
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Stroke; Treatment Outcome; Warfarin; Young Adult	2016
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation. Circulation, 2010, Nov-30, Volume: 122, Issue:22 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyridines; Risk Factors; Stroke; Treatment Outcome; Vitamin K; Warfarin	2010
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke, 2012, Volume: 43, Issue:6 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Radiography; Risk Factors; Warfarin	2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Journal of thrombosis and thrombolysis, 2013, Volume: 35, Issue:2 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Thrombin; Warfarin	2013

Other Studies

79 other study(ies) available for dabigatran and Brain Hemorrhage

Article	Year
Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data. Drug safety, 2022, Volume: 45, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Denmark; Drug-Related Side Effects and Adverse Reactions; Humans; Intracranial Hemorrhages; Pyridones; Rivaroxaban; Warfarin	2022
Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study. Thrombosis research, 2022, Volume: 214 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Craniocerebral Trauma; Dabigatran; Emergency Service, Hospital; Humans; Intracranial Hemorrhages; Ontario; Pyridones; Retrospective Studies; Rivaroxaban	2022
Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants. Journal of the American Heart Association, 2022, 10-04, Volume: 11, Issue:19 Topics: Administration, Intravenous; Aged; Anticoagulants; Dabigatran; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Rivaroxaban; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2022
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Prospective Studies; Stroke; Vitamins	2023
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases. International journal of stroke : official journal of the International Stroke Society, 2020, Volume: 15, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Germany; Humans; Intracranial Hemorrhages; Ischemic Stroke; Retrospective Studies; Stroke; Thrombolytic Therapy	2020
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants. The American journal of emergency medicine, 2020, Volume: 38, Issue:6 Topics: Aged; Aged, 80 and over; Dabigatran; Emergency Service, Hospital; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Registries; Warfarin	2020
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke. Stroke, 2020, Volume: 51, Issue:5 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Australia; Brain Ischemia; Dabigatran; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; New Zealand; Stroke; Tenecteplase; Thrombectomy; Thrombolytic Therapy	2020
Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years. European journal of clinical investigation, 2021, Volume: 51, Issue:6 Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Mortality; Propensity Score; Pyrazoles; Pyridones; Stroke; Warfarin	2021
Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients. CNS drugs, 2021, Volume: 35, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Treatment Outcome	2021
Anticoagulant-related intracranial haemorrhage: time to anticoagulant reversal improving but still slower than thrombolysis for ischaemic stroke. The New Zealand medical journal, 2021, 02-05, Volume: 134, Issue:1529 Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Factors; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; New Zealand; Retrospective Studies; Thrombolytic Therapy; Time Factors; Treatment Outcome; Warfarin	2021
Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge. PloS one, 2021, Volume: 16, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Regression Analysis; Rivaroxaban; Warfarin	2021
Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial Fibrillation. The American journal of cardiology, 2021, 08-01, Volume: 152 Topics: Age Factors; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Warfarin	2021
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke, 2021, Volume: 52, Issue:10 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Case-Control Studies; Dabigatran; Female; Heart Disease Risk Factors; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Risk Factors; Stroke; Treatment Outcome; Vitamin K	2021
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:6 Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Coagulants; Dabigatran; Diffusion Magnetic Resonance Imaging; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2017
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. The journal of trauma and acute care surgery, 2017, Volume: 82, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating	2017
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients. Journal of the American Heart Association, 2017, Apr-24, Volume: 6, Issue:4 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Transfusion; Cause of Death; Comparative Effectiveness Research; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Logistic Models; Male; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke	2017
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection. International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:4 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Female; Germany; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2017
The diagnostic challenge of a vitamin K antagonist with dabigatran use triggering massive intracranial haemorrhage. British journal of anaesthesia, 2017, May-01, Volume: 118, Issue:5 Topics: Aged, 80 and over; Anticoagulants; Dabigatran; Dementia; Drug Overdose; Fatal Outcome; Humans; Intracranial Hemorrhages; Male; Multiple Organ Failure; Skull Fractures; Vitamin K	2017
Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation. British journal of hospital medicine (London, England : 2005), 2017, Jul-02, Volume: 78, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Craniocerebral Trauma; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Stroke; Thiazoles; Warfarin	2017
A comparison between vitamin K antagonists and new oral anticoagulants. British journal of clinical pharmacology, 2017, Volume: 83, Issue:11 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin	2017
Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation. Journal of the neurological sciences, 2018, 05-15, Volume: 388 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Fatal Outcome; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy	2018
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events. Critical pathways in cardiology, 2018, Volume: 17, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin	2018
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. The American journal of cardiology, 2018, 09-01, Volume: 122, Issue:5 Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Rivaroxaban; Spain; Stroke	2018
Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2019, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Female; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Thrombosis; Treatment Outcome	2019
The risk of delayed intracranial hemorrhage with direct acting oral anticoagulants after trauma: A two-center study. American journal of surgery, 2019, Volume: 217, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Brain; Brain Injuries, Traumatic; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neuroimaging; Pyrazoles; Pyridones; Retrospective Studies; Risk; Rivaroxaban; Time Factors; Tomography, X-Ray Computed	2019
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs & aging, 2018, Volume: 35, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Medicare; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Secondary Prevention; Skilled Nursing Facilities; Stroke; Thromboembolism; United States	2018
Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis. Journal of cardiology, 2019, Volume: 73, Issue:3 Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Comparative Effectiveness Research; Dabigatran; Databases, Factual; Embolism; Female; Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Japan; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Treatment Outcome; Warfarin	2019
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients. Stroke, 2018, Volume: 49, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Proportional Hazards Models; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin	2018
Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants. Stroke, 2018, Volume: 49, Issue:12 Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Female; Humans; Incidence; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin	2018
[Efficacy of Idarucizmab in Patients with Intracranial Hemorrhage Preconditioned with Dabigatran]. No shinkei geka. Neurological surgery, 2018, Volume: 46, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Dabigatran; Humans; Intracranial Hemorrhages; Stroke; Warfarin	2018
Hemorrhagic risk and intracranial complications in patients with minor head injury (MHI) taking different oral anticoagulants. The American journal of emergency medicine, 2019, Volume: 37, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Craniocerebral Trauma; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Risk; Rivaroxaban; Thiazoles; Vitamin K; Warfarin	2019
Early-access programme in emergency care: idarucizumab use for rapid dabigatran reversal in critical care patients. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2019, Volume: 26, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Critical Care; Dabigatran; Emergency Treatment; Hemorrhage; Humans; Intracranial Hemorrhages; Thrombolytic Therapy	2019
Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort Study. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020, Volume: 20, Issue:2 Topics: Adult; Antibodies, Monoclonal, Humanized; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2020
Dabigatran etexilate: management in acute ischemic stroke. American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2013, Volume: 22, Issue:2 Topics: Anticoagulants; Benzimidazoles; Cerebral Angiography; Coagulants; Dabigatran; Drug Therapy, Combination; Factor VIIa; Humans; Intracranial Hemorrhages; Intracranial Thrombosis; Male; Middle Aged; Prothrombin; Pyridines; Recombinant Proteins; Severity of Illness Index; Stroke; Suction; Tomography, X-Ray Computed	2013
Dabigatran and postmarketing reports of bleeding. The New England journal of medicine, 2013, Apr-04, Volume: 368, Issue:14 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin	2013
Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage. Journal of thrombosis and thrombolysis, 2014, Volume: 37, Issue:2 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Factor VIIa; Humans; Intracranial Hemorrhages; Male; Recombinant Proteins; Thrombelastography; Thrombin	2014
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. Journal of the American College of Cardiology, 2013, Jun-04, Volume: 61, Issue:22 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Denmark; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Intracranial Hemorrhages; Logistic Models; Male; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Pyridines; Registries; Stroke; Warfarin	2013
Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat. Journal of neuroscience research, 2014, Volume: 92, Issue:1 Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Disease Models, Animal; Fibrinolytic Agents; Intracranial Hemorrhages; Male; Rats; Rats, Wistar; Stroke; Tissue Plasminogen Activator; Warfarin	2014
Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2014, Volume: 10, Issue:2 Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Massachusetts; Middle Aged; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome	2014
Intracranial hemorrhage during dabigatran treatment. Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male	2014
New era of oral anticoagulation for Japanese non-valvular atrial fibrillation patients. Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:6 Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male	2014
Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin. Stroke, 2014, Volume: 45, Issue:8 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Odds Ratio; Retrospective Studies; Warfarin	2014
Outcome following intracranial hemorrhage associated with novel oral anticoagulants. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:1 Topics: Aged, 80 and over; Anticoagulants; Antidotes; Blood Coagulation Tests; Dabigatran; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Neurologic Examination; Pyrazoles; Pyridones; Rivaroxaban; Tomography, X-Ray Computed; Treatment Outcome	2015
Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. The American journal of medicine, 2014, Volume: 127, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Substitution; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; International Normalized Ratio; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Stroke; United States; United States Department of Veterans Affairs; Warfarin	2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation, 2015, Jan-13, Volume: 131, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Dose-Response Relationship, Drug; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Kidney Diseases; Medicare; Proportional Hazards Models; Retrospective Studies; Risk; Socioeconomic Factors; Stroke; Treatment Outcome; United States; Warfarin	2015
Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight. Stroke, 2015, Volume: 46, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin	2015
Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control. Stroke, 2015, Volume: 46, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; China; Cohort Studies; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Time Factors; Warfarin	2015
Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke. Revue neurologique, 2015, Volume: 171, Issue:8-9 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Length of Stay; Male; Pilot Projects; Radiography; Recombinant Proteins; Recurrence; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator	2015
Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age. International journal of medical sciences, 2015, Volume: 12, Issue:4 Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Aging; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kidney; Male; Middle Aged; Odds Ratio; United States; United States Food and Drug Administration; Warfarin	2015
Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis. PloS one, 2015, Volume: 10, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Decision Support Techniques; Embolism; Evidence-Based Medicine; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Rivaroxaban; Stroke; Warfarin	2015
Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage? Annals of hematology, 2015, Volume: 94, Issue:8 Topics: Acute Disease; Aged; Benzimidazoles; beta-Alanine; Dabigatran; Decision Making; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Thrombin Time	2015
The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation. Critical pathways in cardiology, 2015, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Factors; Coagulants; Cohort Studies; Dabigatran; Epistaxis; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Plasma; Platelet Transfusion; Recombinant Proteins; Retrospective Studies; Rivaroxaban	2015
Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants. The Journal of emergency medicine, 2015, Volume: 49, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Patient Admission; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Warfarin	2015
Dabigatran use in elderly patients with atrial fibrillation. Thrombosis and haemostasis, 2016, Volume: 115, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Databases, Factual; Drug Utilization Review; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Quebec; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin	2016
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation. Heart rhythm, 2016, Volume: 13, Issue:2 Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; China; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Outcome Assessment, Health Care; Stroke; Warfarin	2016
Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin. The American surgeon, 2015, Volume: 81, Issue:10 Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; California; Dabigatran; Female; Follow-Up Studies; Glasgow Coma Scale; Humans; Incidence; Intracranial Hemorrhages; Male; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Thromboembolism; Warfarin; Wounds and Injuries	2015
Emergency admissions for major haemorrhage associated with direct oral anticoagulants. Thrombosis research, 2015, Volume: 136, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Patient Admission; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Venous Thrombosis	2015
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Stroke, 2016, Volume: 47, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin	2016
New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series. World neurosurgery, 2016, Volume: 88 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Rivaroxaban; Survival Rate; Treatment Outcome	2016
Dabigatran Plasma Levels in Acute Cerebrovascular Events. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:4 Topics: Aged; Aged, 80 and over; Creatinine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Stroke	2016
Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy. Journal of pharmacy practice, 2017, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Warfarin	2017
A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation. Journal of thrombosis and thrombolysis, 2016, Volume: 42, Issue:3 Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Registries; Stroke; Warfarin	2016
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study. European journal of internal medicine, 2016, Volume: 33 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Israel; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke; Warfarin	2016
Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation. Journal of critical care, 2016, Volume: 36 Topics: Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cardiac Surgical Procedures; Dabigatran; Emergencies; Female; Gastrointestinal Hemorrhage; Heart Transplantation; Hemorrhage; Hemostatics; Heparin; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Laparotomy; Male; Middle Aged; Preoperative Care; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Surgical Procedures, Operative; Thrombocytopenia; Thromboembolism; Vitamin K; Warfarin	2016
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology, 2016, 09-27, Volume: 68, Issue:13 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2016
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. European heart journal, 2017, Mar-21, Volume: 38, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Denmark; Female; Hospitalization; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Vitamin K; Warfarin	2017
Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:9 Topics: Administration, Intranasal; Animals; Animals, Newborn; Antithrombins; Dabigatran; Disease Models, Animal; Extracellular Matrix; Hydrocephalus; Injections, Intraperitoneal; Intracranial Hemorrhages; Maze Learning; Oligopeptides; Pyrroles; Quinazolines; Receptor, PAR-1; Rotarod Performance Test	2017
Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:6 Topics: Administration, Oral; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antithrombins; Blood Coagulation; Brain Ischemia; Dabigatran; Databases, Factual; Drug Approval; Factor Xa Inhibitors; Female; Humans; Incidence; Intracranial Hemorrhages; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Time Factors; Treatment Outcome	2017
Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review. Annals of emergency medicine, 2017, Volume: 69, Issue:5 Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies	2017
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases. Journal of thrombosis and thrombolysis, 2017, Volume: 43, Issue:3 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Disease Management; Drug Interactions; Emergencies; Hemorrhage; Humans; Intracranial Hemorrhages; Middle Aged; Postoperative Hemorrhage; Thrombolytic Therapy	2017
Atrial fibrillation: A promising new anticoagulant for stroke prevention. Nature reviews. Cardiology, 2010, Volume: 7, Issue:1 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Intracranial Hemorrhages; Pyridines; Risk Factors; Stroke; Warfarin	2010
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Annals of internal medicine, 2011, Jan-04, Volume: 154, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Stroke; Warfarin	2011
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. Thrombosis and haemostasis, 2011, Volume: 105, Issue:5 Topics: Aged; Atrial Fibrillation; Benzimidazoles; Canada; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dabigatran; Embolism, Air; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Markov Chains; Pyridines; Quality-Adjusted Life Years; Stroke; Warfarin	2011
New options in anticoagulation for atrial fibrillation. The New England journal of medicine, 2011, Sep-08, Volume: 365, Issue:10 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Intention to Treat Analysis; Intracranial Hemorrhages; Morpholines; Rivaroxaban; Thiophenes; Warfarin	2011
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thrombosis and haemostasis, 2012, Volume: 107, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Cohort Studies; Computer Simulation; Dabigatran; Decision Making, Computer-Assisted; Denmark; Humans; Intracranial Hemorrhages; Morpholines; Population Groups; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin	2012
Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage. Neurosurgery, 2012, Volume: 70, Issue:2 Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Intracranial Hemorrhages; Randomized Controlled Trials as Topic; Risk Factors	2012
Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:5 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Evidence-Based Medicine; Humans; Intracranial Hemorrhages; Patient Safety; Risk Assessment; Risk Factors; Stroke; Treatment Outcome	2012
Removal of dabigatran by hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 61, Issue:3 Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Overdose; Humans; Intracranial Hemorrhages; Male; Renal Dialysis	2013
Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:8 Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Health Care Surveys; Humans; Internet; Intracranial Hemorrhages; Partial Thromboplastin Time; Physicians; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; United States	2013